Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 425

1.

The Value of Left Ventricular Support in Patients With Reduced Left Ventricular Function Undergoing Extensive Revascularization: An Analysis From the PROTECT-II Randomized Trial.

Burke DA, Kundi H, Almonacid A, O'Neill W, Moses J, Kleiman N, Dixon S, Palacios I, Guzman LA, Ohman EM, Popma JJ, Pinto DS.

JACC Cardiovasc Interv. 2019 Oct 14;12(19):1985-1987. doi: 10.1016/j.jcin.2019.07.050. No abstract available.

PMID:
31601396
2.

Bioreactor-based 3D human myocardial ischemia/reperfusion in vitro model: a novel tool to unveil key paracrine factors upon AMI.

Sebastião MJ, Gomes-Alves P, Reis I, Sanchez B, Palacios I, Serra M, Alves PM.

Transl Res. 2019 Sep 7. pii: S1931-5244(19)30194-X. doi: 10.1016/j.trsl.2019.09.001. [Epub ahead of print]

PMID:
31541616
3.

Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients.

Kolte D, Vlahakes GJ, Palacios IF, Sakhuja R, Passeri JJ, Inglessis I, Elmariah S.

J Am Coll Cardiol. 2019 Sep 24;74(12):1532-1540. doi: 10.1016/j.jacc.2019.06.076.

PMID:
31537261
4.

Enhanced response inhibition and reduced midfrontal theta activity in experienced Vipassana meditators.

Andreu CI, Palacios I, Moënne-Loccoz C, López V, Franken IHA, Cosmelli D, Slagter HA.

Sci Rep. 2019 Sep 13;9(1):13215. doi: 10.1038/s41598-019-49714-9.

5.

Ventricular stroke work and vascular impedance refine the characterization of patients with aortic stenosis.

Ben-Assa E, Brown J, Keshavarz-Motamed Z, de la Torre Hernandez JM, Leiden B, Olender M, Kallel F, Palacios IF, Inglessis I, Passeri JJ, Shah PB, Elmariah S, Leon MB, Edelman ER.

Sci Transl Med. 2019 Sep 11;11(509). pii: eaaw0181. doi: 10.1126/scitranslmed.aaw0181.

PMID:
31511424
6.

Impella support and acute kidney injury during high-risk percutaneous coronary intervention: The Global cVAD Renal Protection Study.

Flaherty MP, Moses JW, Westenfeld R, Palacios I, O'Neill WW, Schreiber TL, Lim MJ, Kaki A, Ghiu I, Mehran R.

Catheter Cardiovasc Interv. 2019 Jul 29. doi: 10.1002/ccd.28400. [Epub ahead of print]

PMID:
31355987
7.

CAPN1 Variants as Cause of Hereditary Spastic Paraplegia Type 76.

Garcia-Berlanga JE, Moscovich M, Palacios IJ, Banegas-Lagos A, Rojas-Martinez A, Martinez-Ramirez D.

Case Rep Neurol Med. 2019 Jul 1;2019:7615605. doi: 10.1155/2019/7615605. eCollection 2019.

8.

Alcohol Septal Ablation to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Replacement: First-in-Man Study.

Wang DD, Guerrero M, Eng MH, Eleid MF, Meduri CU, Rajagopal V, Yadav PK, Fifer MA, Palacios IF, Rihal CS, Feldman TE, O'Neill WW.

JACC Cardiovasc Interv. 2019 Jul 8;12(13):1268-1279. doi: 10.1016/j.jcin.2019.02.034.

PMID:
31272671
9.

Dissecting Allo-Sensitization After Local Administration of Human Allogeneic Adipose Mesenchymal Stem Cells in Perianal Fistulas of Crohn's Disease Patients.

Avivar-Valderas A, Martín-Martín C, Ramírez C, Del Río B, Menta R, Mancheño-Corvo P, Ortiz-Virumbrales M, Herrero-Méndez Á, Panés J, García-Olmo D, Castañer JL, Palacios I, Lombardo E, Dalemans W, DelaRosa O.

Front Immunol. 2019 Jun 14;10:1244. doi: 10.3389/fimmu.2019.01244. eCollection 2019.

10.

Percutaneous Mitral Balloon Valvuloplasty: Worldwide Trends.

Palacios IF.

J Am Heart Assoc. 2019 Jul 2;8(13):e012898. doi: 10.1161/JAHA.119.012898. Epub 2019 Jun 29.

11.

Prevalence and clinical correlates of extended mechanical support in patients undergoing high-risk percutaneous coronary intervention in current clinical practice: Insights from the cVAD registry.

Davila CD, Sharma S, Krishnamoorthy P, Rengifo-Moreno P, Palacios IF, O'Neill W, Kapur NK, Witzke CF.

Cardiovasc Revasc Med. 2019 May 11. pii: S1553-8389(19)30299-4. doi: 10.1016/j.carrev.2019.05.001. [Epub ahead of print]

PMID:
31227392
12.

Dose-dependent improvement of cardiac function in a swine model of acute myocardial infarction after intracoronary administration of allogeneic heart-derived cells.

Crisostomo V, Baez C, Abad JL, Sanchez B, Alvarez V, Rosado R, Gómez-Mauricio G, Gheysens O, Blanco-Blazquez V, Blazquez R, Torán JL, Casado JG, Aguilar S, Janssens S, Sánchez-Margallo FM, Rodriguez-Borlado L, Bernad A, Palacios I.

Stem Cell Res Ther. 2019 May 31;10(1):152. doi: 10.1186/s13287-019-1237-6.

13.

Exploring the Use of Technology for Sexual Health Risk-Reduction among Ecuadorean Adolescents.

Reynolds C, Sutherland MA, Palacios I.

Ann Glob Health. 2019 Apr 15;85(1). pii: 57. doi: 10.5334/aogh.35.

14.

YAP/Yorkie in the germline modulates the age-related decline of germline stem cells and niche cells.

Francis D, Chanana B, Fernandez B, Gordon B, Mak T, Palacios IM.

PLoS One. 2019 Apr 3;14(4):e0213327. doi: 10.1371/journal.pone.0213327. eCollection 2019.

15.

Extracellular Vesicles Released by Allogeneic Human Cardiac Stem/Progenitor Cells as Part of Their Therapeutic Benefit.

Hocine HR, Brunel S, Chen Q, Giustiniani J, San Roman MJ, Ferrat YJ, Palacios I, de la Rosa O, Lombardo E, Bensussan A, Charron D, Jabrane-Ferrat N, Al-Daccak R.

Stem Cells Transl Med. 2019 Sep;8(9):911-924. doi: 10.1002/sctm.18-0256. Epub 2019 Mar 28.

16.

Definition of a cell surface signature for human cardiac progenitor cells after comprehensive comparative transcriptomic and proteomic characterization.

Torán JL, López JA, Gomes-Alves P, Aguilar S, Torroja C, Trevisan-Herraz M, Moscoso I, Sebastião MJ, Serra M, Brito C, Cruz FM, Sepúlveda JC, Abad JL, Galán-Arriola C, Ibanez B, Martínez F, Fernández ME, Fernández-Aviles F, Palacios I, R-Borlado L, Vázquez J, Alves PM, Bernad A.

Sci Rep. 2019 Mar 15;9(1):4647. doi: 10.1038/s41598-019-39571-x.

17.

Human cardiac progenitor cell activation and regeneration mechanisms: exploring a novel myocardial ischemia/reperfusion in vitro model.

Sebastião MJ, Serra M, Pereira R, Palacios I, Gomes-Alves P, Alves PM.

Stem Cell Res Ther. 2019 Mar 7;10(1):77. doi: 10.1186/s13287-019-1174-4.

18.

Tox_(R)CNN: Deep learning-based nuclei profiling tool for drug toxicity screening.

Jimenez-Carretero D, Abrishami V, Fernández-de-Manuel L, Palacios I, Quílez-Álvarez A, Díez-Sánchez A, Del Pozo MA, Montoya MC.

PLoS Comput Biol. 2018 Nov 30;14(11):e1006238. doi: 10.1371/journal.pcbi.1006238. eCollection 2018 Nov.

19.

Human cardiac stem cells inhibit lymphocyte proliferation through paracrine mechanisms that correlate with indoleamine 2,3-dioxygenase induction and activity.

Sebastião MJ, Menta R, Serra M, Palacios I, Alves PM, Sanchez B, DelaRosa O, Dalemans W, Lombardo E, Gomes-Alves P.

Stem Cell Res Ther. 2018 Oct 25;9(1):290. doi: 10.1186/s13287-018-1010-2.

20.

Frequency of Complications Including Death from Coronary Artery Bypass Grafting in Patients With Hepatic Cirrhosis.

Singh V, Savani GT, Mendirichaga R, Jonnalagadda AK, Cohen MG, Palacios IF.

Am J Cardiol. 2018 Dec 1;122(11):1853-1861. doi: 10.1016/j.amjcard.2018.08.026. Epub 2018 Sep 7.

PMID:
30293650
21.

Impact of left atrial compliance improvement on functional status after percutaneous mitral valvuloplasty.

Athayde GRS, Nascimento BR, Elmariah S, Lodi-Junqueira L, Soares JR, Saad GP, da Silva JLP, Tan TC, Hung J, Palacios IF, Levine RA, Nunes MCP.

Catheter Cardiovasc Interv. 2019 Jan 1;93(1):156-163. doi: 10.1002/ccd.27831. Epub 2018 Sep 23.

PMID:
30244517
22.

Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry.

Kolte D, Khera S, Vemulapalli S, Dai D, Heo S, Goldsweig AM, Aronow HD, Elmariah S, Inglessis I, Palacios IF, Thourani VH, Sharaf BL, Gordon PC, Abbott JD.

JACC Cardiovasc Interv. 2018 Jun 25;11(12):1175-1185. doi: 10.1016/j.jcin.2018.03.002. Epub 2018 Mar 11.

23.

Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.

Fernández-Avilés F, Sanz-Ruiz R, Bogaert J, Casado Plasencia A, Gilaberte I, Belmans A, Fernández-Santos ME, Charron D, Mulet M, Yotti R, Palacios I, Luque M, Sádaba R, San Román JA, Larman M, Sánchez PL, Sanchís J, Jiménez MF, Claus P, Al-Daccak R, Lombardo E, Abad JL, DelaRosa O, Corcóstegui L, Bermejo J, Janssens S.

Circ Res. 2018 Aug 17;123(5):579-589. doi: 10.1161/CIRCRESAHA.118.312823.

PMID:
29921651
24.

1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Mitral Annular Calcification.

Guerrero M, Urena M, Himbert D, Wang DD, Eleid M, Kodali S, George I, Chakravarty T, Mathur M, Holzhey D, Pershad A, Fang HK, O'Hair D, Jones N, Mahadevan VS, Dumonteil N, Rodés-Cabau J, Piazza N, Ferrari E, Ciaburri D, Nejjari M, DeLago A, Sorajja P, Zahr F, Rajagopal V, Whisenant B, Shah PB, Sinning JM, Witkowski A, Eltchaninoff H, Dvir D, Martin B, Attizzani GF, Gaia D, Nunes NSV, Fassa AA, Kerendi F, Pavlides G, Iyer V, Kaddissi G, Witzke C, Wudel J, Mishkel G, Raybuck B, Wang C, Waksman R, Palacios I, Cribier A, Webb J, Bapat V, Reisman M, Makkar R, Leon M, Rihal C, Vahanian A, O'Neill W, Feldman T.

J Am Coll Cardiol. 2018 May 1;71(17):1841-1853. doi: 10.1016/j.jacc.2018.02.054.

PMID:
29699609
25.

The Role of Impella for Hemodynamic Support in Patients With Aortic Stenosis.

Singh V, Mendirichaga R, Inglessis-Azuaje I, Palacios IF, O'Neill WW.

Curr Treat Options Cardiovasc Med. 2018 Apr 23;20(6):44. doi: 10.1007/s11936-018-0644-9. Review.

PMID:
29682687
26.

ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer.

Pellinen T, Blom S, Sánchez S, Välimäki K, Mpindi JP, Azegrouz H, Strippoli R, Nieto R, Vitón M, Palacios I, Turkki R, Wang Y, Sánchez-Alvarez M, Nordling S, Bützow A, Mirtti T, Rannikko A, Montoya MC, Kallioniemi O, Del Pozo MA.

Sci Rep. 2018 Feb 5;8(1):2338. doi: 10.1038/s41598-018-20161-2.

27.

GH and GHR signaling in human disease.

Guevara-Aguirre J, Guevara A, Palacios I, Pérez M, Prócel P, Terán E.

Growth Horm IGF Res. 2018 Feb;38:34-38. doi: 10.1016/j.ghir.2017.12.006. Epub 2017 Dec 12. Review.

PMID:
29395968
28.

How should I treat a coronary artery to pulmonary artery fistula at an acute stent thrombosis site?

Kannan A, Lee JZ, Saleh L, Kanakadandi U, Rigatelli G, Lee KS, Kasprzak JD, Palacios IF.

EuroIntervention. 2017 Dec 20;13(11):1367-1372. doi: 10.4244/EIJ-D-16-00903. No abstract available.

29.

Cholesterol embolization syndrome: An under-recognized entity in cardiovascular interventions.

Agrawal A, Ziccardi MR, Witzke C, Palacios I, Rangaswami J.

J Interv Cardiol. 2018 Jun;31(3):407-415. doi: 10.1111/joic.12483. Epub 2017 Dec 15. Review.

PMID:
29243285
30.

Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial.

Elmariah S, Fearon WF, Inglessis I, Vlahakes GJ, Lindman BR, Alu MC, Crowley A, Kodali S, Leon MB, Svensson L, Pibarot P, Hahn RT, Thourani VH, Palacios IF, Miller DC, Douglas PS, Passeri JJ; PARTNER Trial Investigators and PARTNER Publications Office.

JACC Cardiovasc Interv. 2017 Dec 11;10(23):2414-2422. doi: 10.1016/j.jcin.2017.09.023.

31.

Comparison of Utilization Trends, Indications, and Complications of Endomyocardial Biopsy in Native Versus Donor Hearts (from the Nationwide Inpatient Sample 2002 to 2014).

Singh V, Mendirichaga R, Savani GT, Rodriguez A, Blumer V, Elmariah S, Inglessis-Azuaje I, Palacios I.

Am J Cardiol. 2018 Feb 1;121(3):356-363. doi: 10.1016/j.amjcard.2017.10.021. Epub 2017 Oct 31.

PMID:
29197471
32.

Active diffusion and advection in Drosophila oocytes result from the interplay of actin and microtubules.

Drechsler M, Giavazzi F, Cerbino R, Palacios IM.

Nat Commun. 2017 Nov 15;8(1):1520. doi: 10.1038/s41467-017-01414-6.

33.

Human Cardiac-Derived Stem/Progenitor Cells Fine-Tune Monocyte-Derived Descendants Activities toward Cardiac Repair.

Dam N, Hocine HR, Palacios I, DelaRosa O, Menta R, Charron D, Bensussan A, El Costa H, Jabrane-Ferrat N, Dalemans W, Lombardo E, Al-Daccak R.

Front Immunol. 2017 Oct 26;8:1413. doi: 10.3389/fimmu.2017.01413. eCollection 2017.

34.

Corrigendum: Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.

Hocine HR, Costa HE, Dam N, Giustiniani J, Palacios I, Loiseau P, Bensussan A, Borlado LR, Charron D, Suberbielle C, Jabrane-Ferrat N, Al-Daccak R.

Sci Rep. 2017 Oct 20;7:46888. doi: 10.1038/srep46888.

35.

DrosAfrica: Building an African biomedical research community using Drosophila.

Martín-Bermudo MD, Gebel L, Palacios IM.

Semin Cell Dev Biol. 2017 Oct;70:58-64. doi: 10.1016/j.semcdb.2017.08.044. Epub 2017 Aug 30. Review.

PMID:
28860103
36.

Coronary revascularization for acute myocardial infarction in the HIV population.

Singh V, Mendirichaga R, Savani GT, Rodriguez AP, Dabas N, Munagala A, Alfonso CE, Cohen MG, Elmariah S, Palacios IF.

J Interv Cardiol. 2017 Oct;30(5):405-414. doi: 10.1111/joic.12433. Epub 2017 Aug 22.

PMID:
28833489
37.

Net atrioventricular compliance is an independent predictor of cardiovascular death in mitral stenosis.

Nunes MCP, Tan TC, Elmariah S, Lodi-Junqueira L, Nascimento BR, do Lago R, Padilha da Silva JL, Reis RCP, Zeng X, Palacios IF, Hung J, Levine RA.

Heart. 2017 Dec;103(23):1891-1898. doi: 10.1136/heartjnl-2016-310955. Epub 2017 Aug 5.

PMID:
28780580
38.

Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study.

Afilalo J, Lauck S, Kim DH, Lefèvre T, Piazza N, Lachapelle K, Martucci G, Lamy A, Labinaz M, Peterson MD, Arora RC, Noiseux N, Rassi A, Palacios IF, Généreux P, Lindman BR, Asgar AW, Kim CA, Trnkus A, Morais JA, Langlois Y, Rudski LG, Morin JF, Popma JJ, Webb JG, Perrault LP.

J Am Coll Cardiol. 2017 Aug 8;70(6):689-700. doi: 10.1016/j.jacc.2017.06.024. Epub 2017 Jul 7.

39.

Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial (Cardiac Stem Cells in Patients With Acute Myocardial Infarction).

Sanz-Ruiz R, Casado Plasencia A, Borlado LR, Fernández-Santos ME, Al-Daccak R, Claus P, Palacios I, Sádaba R, Charron D, Bogaert J, Mulet M, Yotti R, Gilaberte I, Bernad A, Bermejo J, Janssens S, Fernández-Avilés F.

Circ Res. 2017 Jun 23;121(1):71-80. doi: 10.1161/CIRCRESAHA.117.310651. Epub 2017 May 22.

PMID:
28533209
40.

Outcomes of hemodynamic support with Impella in very high-risk patients undergoing balloon aortic valvuloplasty: Results from the Global cVAD Registry.

Singh V, Yadav PK, Eng MH, Macedo FY, Silva GV, Mendirichaga R, Badiye AP, Sakhuja R, Elmariah S, Inglessis I, Alfonso CE, Schreiber TL, Cohen M, Palacios I, O'Neill WW.

Int J Cardiol. 2017 Aug 1;240:120-125. doi: 10.1016/j.ijcard.2017.03.071. Epub 2017 Mar 22.

PMID:
28377189
41.

Corrigendum: Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.

Hocine HR, Costa HE, Dam N, Giustiniani J, Palacios I, Loiseau P, Bensussan A, Borlado LR, Charron D, Suberbielle C, Jabrane-Ferrat N, Al-Daccak R.

Sci Rep. 2017 Mar 16;7:44720. doi: 10.1038/srep44720. No abstract available.

42.

Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury.

Collantes M, Pelacho B, García-Velloso MJ, Gavira JJ, Abizanda G, Palacios I, Rodriguez-Borlado L, Álvarez V, Prieto E, Ecay M, Larequi E, Peñuelas I, Prósper F.

J Transl Med. 2017 Mar 13;15(1):56. doi: 10.1186/s12967-017-1157-0.

43.

Natural disaster management: experience of an academic institution after a 7.8 magnitude earthquake in Ecuador.

Cordero-Reyes AM, Palacios I, Ramia D, West R, Valencia M, Ramia N, Egas D, Rodas P, Bahamonde M, Grunauer M.

Public Health. 2017 Mar;144:134-141. doi: 10.1016/j.puhe.2016.12.003. Epub 2017 Jan 26.

PMID:
28274376
44.

Corrigendum: Finite Element Modeling of A Novel Self-Expanding Endovascular Stent Method in Treatment of Aortic Aneurysms.

Arokiaraj MC, De Santis G, De Beule M, Palacios IF.

Sci Rep. 2017 Feb 20;7:41668. doi: 10.1038/srep41668. No abstract available.

45.

Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells.

Hocine HR, Costa HE, Dam N, Giustiniani J, Palacios I, Loiseau P, Bensussan A, Borlado LR, Charron D, Suberbielle C, Jabrane-Ferrat N, Al-Daccak R.

Sci Rep. 2017 Jan 24;7:41125. doi: 10.1038/srep41125. Erratum in: Sci Rep. 2017 Mar 16;7:44720. Sci Rep. 2017 Oct 20;7:46888.

46.

Ventricular Septal Defect Complicating ST-Elevation Myocardial Infarctions: A Call for Action.

Singh V, Rodriguez AP, Bhatt P, Alfonso CE, Sakhuja R, Palacios IF, Inglessis-Azuaje I, Cohen MG, Elmariah S, O'Neill WW.

Am J Med. 2017 Jul;130(7):863.e1-863.e12. doi: 10.1016/j.amjmed.2016.12.004. Epub 2017 Jan 5.

PMID:
28065768
47.

Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry.

Capodanno D, Gargiulo G, Buccheri S, Chieffo A, Meliga E, Latib A, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar RR, Palacios IF, Kim YH, Buszman PE, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Leon MB, Moses JW, Fajadet J, Lefèvre T, Morice MC, Erglis A, Alfieri O, Serruys PW, Colombo A, Tamburino C; DELTA Investigators.

JACC Cardiovasc Interv. 2016 Nov 28;9(22):2280-2288. doi: 10.1016/j.jcin.2016.08.025.

48.

Comparison of Outcomes of Transcatheter Aortic Valve Replacement Plus Percutaneous Coronary Intervention Versus Transcatheter Aortic Valve Replacement Alone in the United States.

Singh V, Rodriguez AP, Thakkar B, Patel NJ, Ghatak A, Badheka AO, Alfonso CE, de Marchena E, Sakhuja R, Inglessis-Azuaje I, Palacios I, Cohen MG, Elmariah S, O'Neill WW.

Am J Cardiol. 2016 Dec 1;118(11):1698-1704. doi: 10.1016/j.amjcard.2016.08.048. Epub 2016 Aug 30.

PMID:
27665205
49.

Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.

Pyxaras SA, Hunziker L, Chieffo A, Meliga E, Latib A, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar RR, Palacios IF, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Margey R, Agnihotri A, Marra S, Capodanno D, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A, Naber CK.

EuroIntervention. 2016 Aug 5;12(5):e623-31. doi: 10.4244/EIJV12I5A102.

50.

Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention.

Kirtane AJ, Doshi D, Leon MB, Lasala JM, Ohman EM, O'Neill WW, Shroff A, Cohen MG, Palacios IF, Beohar N, Uriel N, Kapur NK, Karmpaliotis D, Lombardi W, Dangas GD, Parikh MA, Stone GW, Moses JW.

Circulation. 2016 Aug 2;134(5):422-31. doi: 10.1161/CIRCULATIONAHA.116.022061.

PMID:
27482004

Supplemental Content

Loading ...
Support Center